Abstract:OBJECTIVE:To investigate the protective effect of microRNA-155 (miR-155) antisense oligonucleotid (ASO) on acute lung injury (ALI) mice by establishing a lentiviral expression vector of ASO of miRNA. METHODS:miR-155 antisense oligonucleotides amplified by polymerase chain reaction (PCR) from genomic, using BamH I and Nhe I double digestion, ligated into lentiviral expression vector. Sequence and virus titer were measured. According to the random number table method, 54 male BALB/c mice of 4-6 weeks old were divided into three groups. ALI animal models were prepared by intraperitoneal injection of 10 mg/kg lipopolysaccharide (LPS). The three groups were injected with 200 μL phosphate buffered saline (PBS) containing 1×108/mL pmiR-155-ASO virus (pmiR-155-ASO group) or 200 μL PBS containing 1×108/mL pSMPUW-miR-GFP empty virus (pmiR-cont group) or the same amount of PBS (PBS group) at 24 hours before the molding. Ten mice in each group were used to observe the 7-day survival rate. Blood samples and lung tissues of the remaining 8 mice were harvested after the model was established, and the levels of serum inflammatory cytokines were determined by enzyme linked immunosorbent assay (ELISA); the expression of miR-155 in lung tissue was detected by real-time reverse transcription-polymerase chain reaction (RT-PCR); histopathological changes of lung and distribution of macrophages were observed under microscope. RESULTS:There was no significant difference in each index between pmiR-cont group and PBS group. The mature miR-155 expression in lung tissue in pmiR-155-ASO group was significantly lower than that in pmiR-cont group (2-ΔΔCt: 4.92±0.72 vs. 15.38±0.60, P < 0.05). Compared with pmiR-cont group, the injury degree of ALI mice after pretreatment with miR-155 ASO was significantly improved, and the 7-day survival rate was significantly increased (72.1% vs. 61.9%, P < 0.05 ); gross lung observation showed that congestion in lung tissue was significantly reduced, and the ratio of wet/dry weight (W/D) of lung was significantly decreased (4.50±0.13 vs. 5.64±0.61, P < 0.05); hematoxylin-eosin (HE) staining showed that inflammatory cell infiltration in lung tissue was decreased, while immunofluorescence assay showed that macrophage infiltration in lung tissue was significant decreased; the levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in serum were significantly decreased [TNF-α (ng/L): 379.8±48.9 vs. 495.9±33.3, IL-6 (ng/L): 262.3±61.8 vs. 355.4±22.6, both P < 0.05], but the level of IL-10 did not change significantly (ng/L: 143.6±32.5 vs. 140.4±22.3, P > 0.05). CONCLUSIONS:miR-155 ASO has the effect of inhibiting LPS-induced inflammatory response and improving prognosis in ALI mice.

Isoflurane Attenuates LPS-induced Acute Lung Injury by Targeting Mir-155-hif1-alpha

Isoflurane Preconditioning Ameliorates Endotoxin-Induced Acute Lung Injury and Mortality in Rats:

Protective Effect of Raloxifene on Lipopolysaccharide and Acid- Induced Acute Lung Injury in Rats

Isoflurane Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting ROS-mediated NLRP3 Inflammasome Activation.

Heme Oxygenase-1 Mediates the Anti-Inflammatory Effect of Isoflurane Preconditioning in LPS-stimulated Macrophages

Isoflurane Post-Treatment Improves Pulmonary Vascular Permeability Via Upregulation of Heme Oxygenase-1

Effects of sevoflurane alleviating LPS-induced acute lung injury by increasing HO-1 expression

Therapeutic Effect of Intravenous Infusion of Perfluorocarbon Emulsion on LPS-Induced Acute Lung Injury in Rats

Sevoflurane Reduces Inflammatory Factor Expression, Increases Viability and Inhibits Apoptosis of Lung Cells in Acute Lung Injury by Microrna-34A-3p Upregulation and STAT1 Downregulation.

[Protective Effect of Microrna-155 Antisense Oligonucleotid on Lipopolysaccharide-Induced Acute Lung Injury in Mice].

Sevoflurane reduces lipopolysaccharide-induced apoptosis and pulmonary fibrosis in the RAW264.7 cells and mice models to ameliorate acute lung injury by eliminating oxidative damages

[Effects of Microrna-155 on Mice with Lipopolysaccharide-Induced Acute Lung Injury].

Isoflurane pretreatment protects against myocardial ischemia/reperfusion injury via mediating lncRNA CASC15/miR-542-3p axis

Sevoflurane Inhibits Nuclear Factor-κB Activation in Lipopolysaccharide-Induced Acute Inflammatory Lung Injury via Toll-Like Receptor 4 Signaling

Desflurane alleviates LPS-induced acute lung injury by modulating let-7b-5p/HOXA9 axis

Isoflurane alleviates systemic inflammation-induced neuroinflammation by decreasing the blood-brain barrier's damage and regulating the microglia's polarization

Anesthetic Isoflurane Posttreatment Attenuates Experimental Lung Injury by Inhibiting Inflammation and Apoptosis

Effects of microRNA-155 inhibitor on JAK/STAT1 signaling pathway in lipopolysaccharide-induced lung injury

Post-conditioning with Sevoflurane Induces Heme Oxygenase-1 Expression Via the PI3K/Akt Pathway in Lipopolysaccharide-Induced Acute Lung Injury.

Hydrogen-rich and hyperoxygenate saline inhibits lipopolysaccharide-induced lung injury through mediating NF-kappa B/NLRP3 signaling pathway in C57BL/6 mice

Hydrogen Inhalation Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Mice